Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Queensland Health

Generated: January 22, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 085461

« Back to Dashboard

NDA 085461 describes LIBRIUM, which is a drug marketed by Valeant Pharm Intl and Valeant Pharms Llc and is included in five NDAs. It is available from eight suppliers. Additional details are available on the LIBRIUM profile page.

The generic ingredient in LIBRIUM is chlordiazepoxide hydrochloride. There are nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the chlordiazepoxide hydrochloride profile page.
Summary for 085461
Applicant:Valeant Pharm Intl
Ingredient:chlordiazepoxide hydrochloride
Formulation / Manufacturing:see details
Pharmacology for NDA: 085461
Suppliers and Packaging for NDA: 085461
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LIBRIUM chlordiazepoxide hydrochloride CAPSULE;ORAL 085461 ANDA AvKARE, Inc. 42291-210 42291-210-90 90 CAPSULE, GELATIN COATED in 1 BOTTLE (42291-210-90)
LIBRIUM chlordiazepoxide hydrochloride CAPSULE;ORAL 085461 ANDA Solco Healthcare US LLC 43547-251 43547-251-10 100 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (43547-251-10)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength5MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
US Department of Justice
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.